Your browser doesn't support javascript.
loading
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic.
Abu-Raddad, Laith J; Chemaitelly, Hiam; Ayoub, Houssein H; Al Kanaani, Zaina; Al Khal, Abdullatif; Al Kuwari, Einas; Butt, Adeel A; Coyle, Peter; Jeremijenko, Andrew; Kaleeckal, Anvar Hassan; Latif, Ali Nizar; Owen, Robert C; Rahim, Hanan F Abdul; Al Abdulla, Samya A; Al Kuwari, Mohamed G; Kandy, Mujeeb C; Saeb, Hatoun; Ahmed, Shazia Nadeem N; Al Romaihi, Hamad Eid; Bansal, Devendra; Dalton, Louise; Al-Thani, Mohamed H; Bertollini, Roberto.
Affiliation
  • Abu-Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, P.O. Box 24144, Doha, Qatar. lja2002@qatar-med.cornell.edu.
  • Chemaitelly H; World Health Organization Collaborating Centre for Disease Epidemiology Analytics On HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar. lja2002@qatar-med.cornell.edu.
  • Ayoub HH; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA. lja2002@qatar-med.cornell.edu.
  • Al Kanaani Z; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, P.O. Box 24144, Doha, Qatar.
  • Al Khal A; World Health Organization Collaborating Centre for Disease Epidemiology Analytics On HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.
  • Al Kuwari E; Department of Mathematics, Statistics, and Physics, Qatar University, Doha, Qatar.
  • Butt AA; Hamad Medical Corporation, Doha, Qatar.
  • Coyle P; Hamad Medical Corporation, Doha, Qatar.
  • Jeremijenko A; Hamad Medical Corporation, Doha, Qatar.
  • Kaleeckal AH; Hamad Medical Corporation, Doha, Qatar.
  • Latif AN; Hamad Medical Corporation, Doha, Qatar.
  • Owen RC; Hamad Medical Corporation, Doha, Qatar.
  • Rahim HFA; Hamad Medical Corporation, Doha, Qatar.
  • Al Abdulla SA; Hamad Medical Corporation, Doha, Qatar.
  • Al Kuwari MG; Hamad Medical Corporation, Doha, Qatar.
  • Kandy MC; College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
  • Saeb H; Primary Health Care Corporation, Doha, Qatar.
  • Ahmed SNN; Primary Health Care Corporation, Doha, Qatar.
  • Al Romaihi HE; Primary Health Care Corporation, Doha, Qatar.
  • Bansal D; Primary Health Care Corporation, Doha, Qatar.
  • Dalton L; Ministry of Public Health, Doha, Qatar.
  • Al-Thani MH; Ministry of Public Health, Doha, Qatar.
  • Bertollini R; Ministry of Public Health, Doha, Qatar.
Sci Rep ; 11(1): 6233, 2021 03 18.
Article in En | MEDLINE | ID: mdl-33737535
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asymptomatic Infections / COVID-19 Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Asia Language: En Journal: Sci Rep Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asymptomatic Infections / COVID-19 Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Asia Language: En Journal: Sci Rep Year: 2021 Document type: Article Affiliation country: Country of publication: